On the recordSeptember 24, 2019
single-source, brand-name drugs that lack generic competition represent one of the largest categories of drug spending growth in the Medicare Part D program.
Source
congress.govsingle-source, brand-name drugs that lack generic competition represent one of the largest categories of drug spending growth in the Medicare Part D program.
Discussing the impact of brand-name drugs on Medicare spending.
Share
More from Frank Pallone
Amtrak, as the owner and operator of the Northeast Corridor infrastructure, must take extraordinary steps to inspect critical assets, strategically position personnel and equipment, strengthen coordination with NJ TRANSIT, and ensure the…
I will continue to call for accountability and carry out oversight of this facility.
“It’s time to finally end the process of springing forward and falling back,”
Big Tech has had a free pass for far too long while kids and teens face real harm online, including predatory design features, dangerous chatbots, and data brokers profiting off their personal information.